This information was published on 2026-05-18T11:11:27 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2426097 |
| (220) |
07 Feb 2024
|
| (500) |
Provisions of paragraph 44(3)(b) and/or Reg 4.15A(3)(b) applied.
|
| (511) (510) |
Class 5
Ophthalmic preparations, including eye drops. |
| (540) | REFRESH FUSION |
| (550) | Word |
| (730) |
Allergan, Inc.
|
| (750) |
Spruson & Ferguson
|
Find out more about publications on the About page.